Javascript must be enabled to continue!
Abstract B022: Acinar-to-ductal metaplasia index (ADMI): A quantifiable measure of ADM
View through CrossRef
Abstract
Acinar to ductal metaplasia (ADM) is thought to be a natural adaptive response to injury by which downregulation of digestive enzymes mitigates tissue damage and facilitates repair. However, this latent plasticity is also a critical gateway to cancer. In the context of a KRAS mutation – the driver mutation in pancreatic cancer – ADM is co-opted, causing acinar cells to progress into precancerous lesions instead of returning to a normal acinar state. ADM has various stages of severity marked by severe histologic changes replacing acinar morphology and markers with those of ductal epithelium. While this descriptive state of ADM is well established in pancreas biology, the field has lacked an objective measure to quantify various stages of deviation from the homeostatic acinar cell state. Here, we leverage FixNCut, a novel method for single-cell transcriptomic analysis of the pancreas, to develop an index tool that allows researchers to objectively measure the deviation of metaplastic acinar cells from normal acinar cell identity. The ADM Index, or ADMI, is based on 16 signature genes upregulated only in acinar cells in ADM, and is corroborated with GeoMx WTA data. We observe an increased ADMI score in acinar cells following pancreatitis, with perduring detectable elevation of ADM specific genes 14 days post-inflammation. ADMI was also validated in independent single-cell and bulk RNA-seq data, demonstrating the utility of scoring ADMI across studies and in diverse perturbations. We further apply ADMI to the context of recurrent weekly acute pancreatitis in mice and observe progressively increasing ADMI score sequentially at 2 week, 4 week, and 6 week timepoints. Our findings validate ADMI as a robust, objective standard that researchers can use in their own datasets to quantify deviation of individual acinar cells from normal identity, to investigate single-cell heterogeneity of these deviations, and to observe how these deviations change over time or following diverse stressors.
Citation Format: Katherine J Aney, Woo-Jeong Jeong, Pal Koak, Sahar Nissim. Acinar-to-ductal metaplasia index (ADMI): A quantifiable measure of ADM [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr B022.
American Association for Cancer Research (AACR)
Title: Abstract B022: Acinar-to-ductal metaplasia index (ADMI): A quantifiable measure of ADM
Description:
Abstract
Acinar to ductal metaplasia (ADM) is thought to be a natural adaptive response to injury by which downregulation of digestive enzymes mitigates tissue damage and facilitates repair.
However, this latent plasticity is also a critical gateway to cancer.
In the context of a KRAS mutation – the driver mutation in pancreatic cancer – ADM is co-opted, causing acinar cells to progress into precancerous lesions instead of returning to a normal acinar state.
ADM has various stages of severity marked by severe histologic changes replacing acinar morphology and markers with those of ductal epithelium.
While this descriptive state of ADM is well established in pancreas biology, the field has lacked an objective measure to quantify various stages of deviation from the homeostatic acinar cell state.
Here, we leverage FixNCut, a novel method for single-cell transcriptomic analysis of the pancreas, to develop an index tool that allows researchers to objectively measure the deviation of metaplastic acinar cells from normal acinar cell identity.
The ADM Index, or ADMI, is based on 16 signature genes upregulated only in acinar cells in ADM, and is corroborated with GeoMx WTA data.
We observe an increased ADMI score in acinar cells following pancreatitis, with perduring detectable elevation of ADM specific genes 14 days post-inflammation.
ADMI was also validated in independent single-cell and bulk RNA-seq data, demonstrating the utility of scoring ADMI across studies and in diverse perturbations.
We further apply ADMI to the context of recurrent weekly acute pancreatitis in mice and observe progressively increasing ADMI score sequentially at 2 week, 4 week, and 6 week timepoints.
Our findings validate ADMI as a robust, objective standard that researchers can use in their own datasets to quantify deviation of individual acinar cells from normal identity, to investigate single-cell heterogeneity of these deviations, and to observe how these deviations change over time or following diverse stressors.
Citation Format: Katherine J Aney, Woo-Jeong Jeong, Pal Koak, Sahar Nissim.
Acinar-to-ductal metaplasia index (ADMI): A quantifiable measure of ADM [abstract].
In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA.
Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr B022.
Related Results
An unexpected role for the conserved ADAM-family metalloprotease ADM-2 in
Caenorhabditis elegans
molting
An unexpected role for the conserved ADAM-family metalloprotease ADM-2 in
Caenorhabditis elegans
molting
Abstract
Molting is a widespread developmental process in which the external extracellular matrix (ECM), the cuticle, is remodeled to allow for o...
361. PHOTODYNAMIC THERAPY IN THE TREATMENT OF ESOPHAGEAL MUCOSAL METAPLASIA IN CHILDREN
361. PHOTODYNAMIC THERAPY IN THE TREATMENT OF ESOPHAGEAL MUCOSAL METAPLASIA IN CHILDREN
Abstract
Background
The urgency of the problem of gastroesophageal reflux disease (GERD) in pediatrics is due to the high preval...
Radiological Insights into Acellular Dermal Matrix Integration in Post-Mastectomy Breast Reconstruction: Implications for Cancer Patient Management
Radiological Insights into Acellular Dermal Matrix Integration in Post-Mastectomy Breast Reconstruction: Implications for Cancer Patient Management
Background: Breast reconstruction (BR) following mastectomy plays a critical role in restoring breast contour and improving patients’ quality of life. Acellular dermal matrices (AD...
Immunological and Molecular Insights into Acinar-Ductal Metaplasia and Atypical Flat Lesions as Precursor Lesions of Pancreatic Ductal Adenocarcinoma
Immunological and Molecular Insights into Acinar-Ductal Metaplasia and Atypical Flat Lesions as Precursor Lesions of Pancreatic Ductal Adenocarcinoma
Abstract
Introduction
Pancreatic ductal adenocarcinoma (PDAC) is known to develop through a stepwise progression from precursor lesions, such as ...
Abstract PO-073: Inactivation of Notch4 attenuated pancreatic tumorigenesis in mice
Abstract PO-073: Inactivation of Notch4 attenuated pancreatic tumorigenesis in mice
Abstract
Expression of the Notch family of receptors are often upregulated in pancreatic ductal adenocarcinoma (PDAC), however, the functional impacts of the Notch s...
Effects of a moderate‐intensity static magnetic field and adriamycin on K562 cells
Effects of a moderate‐intensity static magnetic field and adriamycin on K562 cells
AbstractThe aim of this study was to investigate whether a moderate‐intensity static magnetic field (SMF) can enhance the killing effect of adriamycin (ADM) on K562 cells, and to e...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Research of Synergetic Reversal in Adriamycin - Resistance by the Application of Magnetic Nanoparticle of Fe3O4 and Tetrandrine in K562/A02 Leukemic Cells.
Research of Synergetic Reversal in Adriamycin - Resistance by the Application of Magnetic Nanoparticle of Fe3O4 and Tetrandrine in K562/A02 Leukemic Cells.
Objective: To prepare functionalized Fe3O4-magnetic nanoparticles(Fe3O4-MNPs) loaded with adriamycin(ADM) or Fe3O4-MNPs co-polymerized with ADM and tetrandrine(Tet) to investigate ...

